Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Myelin Volume Measurement Tool Receives CE Mark

By MedImaging International staff writers
Posted on 25 Apr 2017
A tool that can be used for rapid quantification of the estimated myelin volume in the brain for diagnostic imaging has been awarded the CE-mark (Conformité Européenne) for clinical use in Europe.

According to the developer of the post-processing software, the tool is compatible with Magnetic Resonance (MR) scanners from leading vendors.

The Rapid Estimation of Myelin for Diagnostic Imaging (REMyDI) tool is part of the SyntheticMR SyMRI NEURO REMyDI post-processing software package. Myelin quantification enables clinicians to monitor myelin degeneration in patients with neurodegenerative disorders, and diseases that cause brain demyelination. Clinicians can also use the tool to follow myelination in the developing brain. The new REMyDI feature will provide clinicians with automatic myelin volume measurement using data from a single 5-6-minute quantitative MRI scan. Post-processing is automatic and takes less than 10 seconds to complete.

The SyMRI software package enables clinicians to capture multiple image contrasts in one MR scan. The contrast can be adjusted following the scan to create additional images. The system provides automatic segmentation of brain tissue for objective decision support based on quantitative data. Scanner settings can be matched between scans to enable accurate comparison between exams. The images can also be matched with previous images, and conventional protocols. The SyMRI software package is CE-marked, and is pending 510(k) approval from the US Food and Drug Administration (FDA).


Gold Member
Solid State Kv/Dose Multi-Sensor
AGMS-DM+
New
Ultrasound Table
Powered Ultrasound Table-Flat Top
New
X-Ray QA Meter
Piranha CT
DR Flat Panel Detector
1500L
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to MedImaging.net and get complete access to news and events that shape the world of Radiology.
  • Free digital version edition of Medical Imaging International sent by email on regular basis
  • Free print version of Medical Imaging International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of Medical Imaging International in digital format
  • Free Medical Imaging International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Ultrasound

view channel
Image: CAM figures of testing images (Photo courtesy of SPJ; DOI:10.34133/research.0319)

Diagnostic System Automatically Analyzes TTE Images to Identify Congenital Heart Disease

Congenital heart disease (CHD) is one of the most prevalent congenital anomalies worldwide, presenting substantial health and financial challenges for affected patients. Early detection and treatment of... Read more

Nuclear Medicine

view channel
Image: Researchers have identified a new imaging biomarker for tumor responses to ICB therapy (Photo courtesy of 123RF)

New PET Biomarker Predicts Success of Immune Checkpoint Blockade Therapy

Immunotherapies, such as immune checkpoint blockade (ICB), have shown promising clinical results in treating melanoma, non-small cell lung cancer, and other tumor types. However, the effectiveness of these... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.